Evaluation of Transdermal Nicotine Replacement Therapy (NRT) Activity Through Metabolic Induction

NCT01438944 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Smoking
Addiction

Interventions

DRUG: Nicabate 21mg transdermal NRT

Sponsor

The Queen Elizabeth Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]